m5C修饰调节因子在泛癌中的作用和潜在抑制剂分析

doi:10.3969/j.issn.1009-976X.2023.01.011

摘要/Abstract

摘要： 目的 RNA的5-甲基胞嘧啶（m5C）修饰参与多种生理和病理过程,特别是在肿瘤的发生和发展中。本研究通过泛癌中m5C修饰调节因子分析泛癌中的m5C水平与预后的关系,并探究潜在的m5C抑制药物。方法从癌症基因图谱（TCGA）数据库下载33种癌症的RNA-Seq数据,使用R软件分析m5C修饰调节因子在癌和癌旁组织中的表达水平。随后,我们通过CMap预测可能抑制泛癌中m5C修饰的潜在药物,并通过m5C dot blot和细胞生长实验验证其抑制作用。结果在大多数肿瘤类型中,m5C的Writers和Readers都有着明显的高表达,肿瘤组织m5C总体水平高的相较于m5C总体水平低的患者,其总体生存期（OS）显著缩短（P<0.05）。重要的是,预测的m5C抑制药物可以有效抑制癌细胞的总体m5C水平以及增殖。结论我们的研究表明,在多种癌症类型中,高水平的m5C修饰和m5C修饰调节因子的异常表达与恶性肿瘤密切相关,表明m5C修饰调节因子可能是有希望的预后生物标志物,并可作为癌症治疗的潜在靶点。

关键词: m5C修饰, 泛癌, 预后, m5C抑制剂

Abstract: Objective 5-methylcytosine （m5C） modification of RNA is involved in a variety of physiological and pathological processes, especially in the occurrence and development of tumors. In this study, the relationship between the level of m5C in pan-cancer and prognosis was analyzed by m5C modified regulatory genes, and the potential m5C inhibitory were explored. Methods the RNA-Seq data of 33 cancers were downloaded from the cancer gene map （TCGA） database, and the expression levels of M5C regulatory genes in cancer and paracancerous tissues were analyzed by R software. Then, we predicted the potential drugs that might inhibit m5C modification in pan-cancer by The Connectivity Map （CMap）, and verified their inhibitory effects by the m5C dot blot and cell viability assay. Results In most tumor types, Writers and Readers of m5C were significantly overexpressed. The overall survival times （OS） of patients with high level of m5C was significantly shorter than that of patients with low level of m5C. Importantly, the predicted m5C inhibiting drugs can effectively inhibit the total m5C level and proliferation of cancer cells. Conclusion Our study shows that in many types of cancers, the high level of m5C modification and the abnormal expression of m5C regulatory molecules are closely related to malignant tumors, indicating that m5C modification regulators may be promising biomarkers for prognosis. and can be used as valuable targets for cancer treatment.

Key words: 5-methylcytosine modification, pan-cancer, prognosis, m5C inhibitor

中图分类号:

R730

赖正灏, 梁国润, 罗曼莉. m5C修饰调节因子在泛癌中的作用和潜在抑制剂分析[J]. 岭南现代临床外科, 2023, 23(01): 64-70.

LAI Zheng-hao, LIANG Guo-run, LUO Man-li. Analysis of the function and potential inhibitors of 5-methylcytosine modification regulators in cancer[J]. Lingnan Modern Clinics In Surgery, 2023, 23(01): 64-70.

参考文献

[1] Yang X, Yang Y, Sun BF, et al.5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m(5)C reader[J]. Cell Res, 2017, 27(5): 606-625.
[2] Amort T, Rieder D, Wille A, et al.Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain[J]. Genome Biol, 2017, 18: 16.
[3] Van Haute L, Lee SY, McCann BJ, et al. NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs[J]. Nucleic Acids Res, 2019, 47(16): 8720-8733.
[4] Heissenberger C, Liendl L, Nagelreiter F, et al.Loss of the ribosomal RNA methyltransferase NSUN5 impairs global protein synthesis and normal growth[J]. Nucleic Acids Res, 2019, 47(22): 11807-11825.
[5] Xue C, Zhao Y, Li L.Advances in RNA cytosine-5 methylation: detection, regulatory mechanisms, biological functions and links to cancer[J]. Biomarker Res, 2020, 8(1): :43.
[6] Garcia-Vilchez R, Sevilla A, Blanco S.Post-transcriptional regulation by cytosine-5 methylation of RNA[J]. Biochim Biophys Acta Gene Regul Mech, 2019, 1862(3): 240-252.
[7] Cheray M, Etcheverry A, Jacques C, et al.Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme[J]. Mol Cancer, 2020, 19(1): 36.
[8] Fu LJ, Guerrero CR, Zhong N, et al.Tet-Mediated Formation of 5-Hydroxymethylcytosine in RNA[J]. J Am Chem Soc, 2014, 136(33): 11582-11585.
[9] Kawarada L, Suzuki T, Ohira T, et al.ALKBH1 is an RNA dioxygenase responsible for cytoplasmic and mitochondrial tRNA modifications[J]. Nucleic Acids Res, 2017, 45(12): 7401-7415.
[10] Chen X, Li A, Sun B-F, et al.5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs[J]. Nat Cell Biol, 2019, 21(8): 978-990.
[11] Chen H, Yang H, Zhu X, et al.m(5)C modification of mRNA serves a DNA damage code to promote homologous recombination[J]. Nat Commun, 2020, 11(1):2834.
[12] Nombela P, Miguel-Lopez B, Blanco S.The role of m(6)A, m(5)C and Psi RNA modifications in cancer: Novel therapeutic opportunities[J]. Mol Cancer, 2021, 20(1): 30.
[13] Chen YS, Yang WL, Zhao YL, Yang YG.Dynamic transcriptomic m(5)C and its regulatory role in RNA processing[J]. Wiley Interdiscip Rev RNA, 2021, 12(4):e1639
[14] Shi H, Chai P, Jia R, Fan X.Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation[J]. Mol Cancer, 2020, 19(1):78.
[15] Liang W, Lin Z, Du C, et al.mRNA modification orchestrates cancer stem cell fate decisions[J]. Mol Cancer, 2020, 19(1): 38.
[16] Han X, Wang M, Zhao Y-L, et al.RNA methylations in human cancers[J]. Seminars in cancer biology, 2020,75:97-115
[17] Huang W, Qi CB, Lv SW, et al.Determination of DNA and RNA Methylation in Circulating Tumor Cells by Mass Spectrometry[J]. Anal Chem, 2016, 88(2): 1378-1384.
[18] Mei L, Shen C, Miao R, et al.RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57(Kip2) by an m(5)C-dependent manner[J]. Cell Death Dis, 2020, 11(4): 270.
[19] Blanco S, Bandiera R, Popis M, et al.Stem cell function and stress response are controlled by protein synthesis[J]. Nature, 2016, 534(7607): 335-340.
[20] Okamoto M, Fujiwara M, Hori M, et al.tRNA modifying enzymes, NSUN2 and METTL1, determine sensitivity to 5-fluorouracil in HeLa cells[J]. PLoS Genet, 2014, 10(9): e1004639.
[21] He Y, Yu X, Li J, et al.Role of m(5)C-related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma[J]. Am J of Transl Res, 2020, 12(3): 912-922.
[22] Kumar S, Mohapatra T.Deciphering Epitranscriptome: Modification of mRNA Bases Provides a New Perspective for Post-transcriptional Regulation of Gene Expression[J]. Front Cell Dev Biol, 2021, 9:628415.
[23] Bohnsack KE, Hobartner C, Bohnsack MT.Eukaryotic 5-methylcytosine (m(5)C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease[J]. Genes (Basel), 2019, 10(2):102.
[24] Sun Z, Xue S, Zhang M, et al.Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma[J]. Oncogene, 2020, 39(45): 6906-6919.
[25] Wang JZ, Zhu W, Han J, et al.The role of the HIF-1alpha/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer[J]. Cancer Commun (Lond), 2021, 41(7):560-575.
[26] Li Y, Li J, Luo M, et al.Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma[J]. Cancer Lett, 2018, 430: 57-66.
[27] Okamoto M, Hirata S, Sato S, et al.Frequent Increased Gene Copy Number and High Protein Expression of tRNA (Cytosine-5-)-Methyltransferase (NSUN2) in Human Cancers[J]. DNA Cell Biol, 2012, 31(5): 660-671.
[28] Chellamuthu A, Gray SG.The RNA Methyltransferase NSUN2 and Its Potential Roles in Cancer[J]. Cells, 2020, 9(8): 22.